Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I

Turner, Nigel, Li, Jing-Ya, Gosby, Alison, To, Sabrina W.C., Cheng, Zhe, Miyoshi, Hiroyuki, Taketo, Makoto M., Cooney, Gregory J. +5 more·2008·Diabetes

Cited by (541)

Items 101–200 of 541

  1. The Implication of Oxidative Stress and AMPK-Nrf2 Antioxidative Signaling in Pneumonia Pathogenesis
    Weitong Xu, Tingting Zhao, Hengyi Xiao · 2020 · Frontiers in Endocrinology
  2. AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
    Joo-Won Lee, Sung Sik Choe, Hagoon Jang, Jiyeong Kim, Hyun Woo Jeong, Hyunsun Jo, Kyeong-Hoon Jeong, Surendar Tadi, Myoung Gyu Park, Tae Hwan Kwak et al. · 2012 · Journal of Lipid Research
  3. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement
    Hang Zhou, Lili Feng, Fang Xu, Yi Sun, Yuxiang Ma, Xiong Zhang, Hailiang Liu, Ge Xu, Xuefeng Wu, Yan Shen et al. · 2017 · Biomedicine & Pharmacotherapy
  4. Metformin and metabolic diseases: a focus on hepatic aspects
    Juan Zheng, Shih‐Lung Woo, Xiang Hu, Rachel E. Botchlett, Lulu Chen, Yuqing Huo, Chaodong Wu · 2015 · Frontiers of Medicine
  5. Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation
    Miao Xu, Yuanyuan Xiao, Jun Yin, Wolin Hou, YU Xue-ying, Li Shen, Fang Liu, Li Wei, Weiping Jia · 2014 · PLoS ONE
  6. Cardiovascular and metabolic effects of Berberine
    Flora Affuso · 2010 · World Journal of Cardiology
  7. Activation of AMPK by Pterostilbene Suppresses Lipogenesis and Cell-Cycle Progression in p53 Positive and Negative Human Prostate Cancer Cells
    Victor Chia-Hsiang Lin, Ya-Chu Tsai, Jia-Ni Lin, Ling-Ling Fan, Min‐Hsiung Pan, Chi‐Tang Ho, Jiumn‐Yih Wu, Tzong‐Der Way · 2012 · Journal of Agricultural and Food Chemistry
  8. Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs—A mechanistic revisit to understand their mode of action
    Prachi Gupta, Manju Bala, Sanjeev Kumar Gupta, Anita Dua, Rajesh Dabur, Elisha R. Injeti, Ashwani Mittal · 2016 · Pharmacological Research
  9. Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation
    Tamara Yuliett Forbes-Hernández, Francesca Giampieri, Massimiliano Gasparrini, Sadia Afrin, Luca Mazzoni, Mario David Cordero, Bruno Mezzetti, José Luis Quiles, Maurizio Antonio Battino · 2017 · Nutrients
  10. Chicoric Acid Is an Antioxidant Molecule That Stimulates AMP Kinase Pathway in L6 Myotubes and Extends Lifespan in Caenorhabditis elegans
    Audrey Schlernitzauer, Catherine Oiry, Raphael Hamad, Simon Galas, Fabienne Cortade, Béatrice Chabi, François Casas, Laurence Pessemesse, Gilles Fouret, Christine Feillet‐Coudray et al. · 2013 · PLoS ONE
  11. CYP2D plays a major role in berberine metabolism in liver of mice and humans
    Ying Guo, Feng Li, Xiaochao Ma, Xingguo Cheng, Hong‐Hao Zhou, Curtis D. Klaassen · 2011 · Xenobiotica
  12. Small molecules from natural sources, targeting signaling pathways in diabetes
    Qiong Liu, Lili Chen, Lihong Hu, Yue‐Wei Guo, Xu Shen · 2010 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  13. Antidiabetic plant-derived nutraceuticals: a critical review
    Jayapal Naveen, Vallikannan Baskaran · 2017 · European Journal of Nutrition
  14. Adrenergic Regulation of AMP-activated Protein Kinase in Brown Adipose Tissue in Vivo
    Thomas Pulinilkunnil, Huamei He, Dong Kong, Kenji Asakura, Odile D. Peroni, Anna D. Lee, Barbara B. Kahn · 2011 · Journal of Biological Chemistry
  15. Saturated- and n-6 Polyunsaturated-Fat Diets Each Induce Ceramide Accumulation in Mouse Skeletal Muscle: Reversal and Improvement of Glucose Tolerance by Lipid Metabolism Inhibitors
    Georgia Frangioudakis, J M Garrard, Katy Raddatz, Jerry L. Nadler, Todd W. Mitchell, Carsten Schmitz‐Peiffer · 2010 · Endocrinology
  16. The Role of AMPK Signaling in Brown Adipose Tissue Activation
    Jamie I. van der Vaart, Mariëtte R. Boon, Riekelt H. Houtkooper · 2021 · Cells
  17. Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation
    Masahiro Takahara, Akinobu Takaki, Sakiko Hiraoka, Takuya Adachi, Yasuyuki Shimomura, Hiroshi Matsushita, Tien Thi Thuy Nguyen, KAZUKO A. KOIKE, Airi Ikeda, Shiho Takashima et al. · 2019 · Scientific Reports
  18. Selective Inhibition of Deactivated Mitochondrial Complex I by Biguanides
    Satoshi Matsuzaki, Kenneth Michael Humphries · 2015 · Biochemistry
  19. Antidiabetic Effect of Salvianolic Acid A on Diabetic Animal Models via AMPK Activation and Mitochondrial Regulation
    Guifen Qiang, Xiuying Yang, Lili Shi, Hengai Zhang, Bainian Chen, Yan Zhao, Mian Zu, Dan Zhou, Jing Guo, Haiguang Yang et al. · 2015 · Cellular Physiology and Biochemistry
  20. Demethyleneberberine, a Natural Mitochondria-Targeted Antioxidant, Inhibits Mitochondrial Dysfunction, Oxidative Stress, and Steatosis in Alcoholic Liver Disease Mouse Model
    Zhang, Pengcheng, Qiang, Xiaoyan, Zhang, Miao, Ma, Dongshen, Zhao, Zheng, Zhou, Cuisong, Liu, Xie, Li, Ruiyan, Chen, Huan, Zhang, Yubin · 2015 · The Journal of Pharmacology and Experimental Therapeutics
  21. AMP-activated protein kinase: An emerging target for ginseng
    Kyong Ju Jeong, Go Woon Kim, Sung Hyun Chung · 2014 · Journal of Ginseng Research
  22. Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
    Bronwyn D. Hegarty, Nigel A. Turner, Gregory James Cooney, Edward W. Kraegen · 2009 · Acta Physiologica
  23. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
    Lieqiang Xu, Guoshu Lin, Qiuxia Yu, Qiaoping Li, Liting Mai, Juanjuan Cheng, Jianhui Xie, Yuhong Liu, Ziren Su, Yucui Li · 2021 · Frontiers in Pharmacology
  24. Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
    Xiaoting Luo, Rongrong Li, Liang‐Jun Yan · 2015 · Journal of Diabetes Research
  25. Adenosine Monophosphate–Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation
    Sukriti Krishan, Des Raymond Richardson, Sumit Sahni · 2014 · Molecular Pharmacology
  26. Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice
    Yongning Sun, Chenxi Jin, Xiaoying Zhang, Weiping Jia, Jiamei Le, Jianping Ye · 2018 · Nutrition and Diabetes
  27. Berberine: Pharmacological Features in Health, Disease and Aging
    Amin Gasmi, Farah Asghar, Saba Zafar, Petro Oliinyk, O.P. Khavrona, Roman Lysiuk, Massimiliano Peana, Salva Piscopo, Halyna Antonyak, Joeri Jan Pen et al. · 2023 · Current Medicinal Chemistry
  28. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats
    Jindong Zhao, Yan Li, Min Sun, Chanjuan Yu, Jia-Yun Li, Si-Hai Wang, Di Yang, Chenglin Guo, Xue Du, Wenjin Zhang et al. · 2021 · World Journal of Gastroenterology
  29. Berberine modulates insulin signaling transduction in insulin-resistant cells
    Lizhong Liu, Stanley C.K. Cheung, Linlin Lan, Stanley K. S. Ho, Hong‐Xi Xu, Juliana C.N. Chan, Peter C.Y. Tong · 2009 · Molecular and Cellular Endocrinology
  30. Berberine acutely activates the glucose transport activity of GLUT1
    Alexandra Cok, Christina L. Rosenberger, Matthew J. Salie, Daniel S. Oram, Jude Chenge, Larry L. Louters · 2011 · Biochimie
  31. Research progress on the pharmacological effects of berberine targeting mitochondria
    Xinyi Fang, Haoran Wu, Jiahua Wei, Runyu Miao, Yanjiao Zhang, Jiaxing Tian · 2022 · Frontiers in Endocrinology
  32. RETRACTED: Redox Regulation of the AMP-Activated Protein Kinase
    Han, Yingying, Wang, Qilong, Song, Ping, Zhu, Yi, Zou, Ming-Hui · 2010 · PLoS ONE · Retracted
  33. Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice
    Cailan Li, Na Dong, B H Wu, Zhimi Mo, Jianhui Xie, Qiang Lü · 2021 · Phytomedicine
  34. Antidiabetic Properties of Berberine: From Cellular Pharmacology to Clinical Effects
    Arrigo F.G. Cicero, Elisa Tartagni · 2012 · Hospital Practice
  35. Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism
    Yuan Jun Gu, Chunting Qi, Xiaoxiao Sun, Xiuquan Ma, Haohao Zhang, Lihong Hu, Junying Yuan, Qiang Yu · 2012 · Biochemical Pharmacology
  36. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models
    Zhe Cheng, An-feng Chen, Fang Wu, Sheng Li, Hankun Zhang, Min Gu, Yuanyuan Li, Li-Na Zhang, Lihong Hu, Jing-Ya Li et al. · 2010 · Bioorganic & Medicinal Chemistry
  37. Mechanism of insulin resistance in obesity: a role of ATP
    Jianping Ye · 2021 · Frontiers of Medicine
  38. Research progress on pharmacological effects and bioavailability of berberine
    Yulong Cui, Quanying Zhou, Min Jin, Siqi Jiang, Peizhao Shang, Xiaofan Dong, Lingjun Li · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  39. Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP 72 as an upstream target
    Xiao‐Yi Zeng, Hao Wang, Fang Bai, Xiu Zhou, Song‐Pei Li, Luping Ren, Ruo‐Qiong Sun, Charlie Changli Xue, Hualiang Jiang, Lihong Hu et al. · 2015 · British Journal of Pharmacology
  40. Berberine Suppresses Adipocyte Differentiation via Decreasing CREB Transcriptional Activity
    Juan Zhang, Hongju Tang, Ruyuan Deng, Ning Wang, Yuqing Zhang, Yao Wang, Yun Liu, Fengying Li, Xiao Wang, Libin Zhou · 2015 · PLoS ONE
  41. Ketosis may promote brain macroautophagy by activating Sirt1 and hypoxia-inducible factor-1
    Mark Frederick McCarty, James J. DiNicolantonio, James Henry O’Keefe · 2015 · Medical Hypotheses
  42. Berberine suppresses gero-conversion from cell cycle arrest to senescence
    Hong Zhao, H. Dorota Halicka, Jiangwei Li, Zbigniew Darżynkiewicz · 2013 · Aging
  43. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats
    Guohua Li, Wenjuan Xing, Min Zhang, Fenghao Geng, Hongyan Yang, Haifeng Zhang, Xing Zhang, Jia Li, Ling Dong, Feng Gao · 2018 · American Journal of Physiology-Heart and Circulatory Physiology
  44. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study
    Li Liu, Yunli Yu, Jiansong Yang, Li Yang, Yao‐Wu Liu, Yan Liang, Xiaodong Liu, Lin Ying Xie, Guangji Wang · 2010 · Naunyn-Schmiedeberg s Archives of Pharmacology
  45. Berberine improves mesenteric artery insulin sensitivity through up‐regulating insulin receptor‐mediated signalling in diabetic rats
    Fenghao Geng, Guo‐Hua Li, Xing Zhang, Peng Zhang, Mingqing Dong, Zhijing Zhao, Yuan Zhang, Ling Dong, Feng Gao · 2016 · British Journal of Pharmacology
  46. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis
    Yanwen Wang, Jeffrey A. Zidichouski · 2018 · Cholesterol
  47. Autophagy-nutrient sensing pathways in diabetic complications
    Urvi M. Parmar, Manjiri P. Jalgaonkar, Yogesh Anant Kulkarni, Manisha J. Oza · 2022 · Pharmacological Research
  48. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice
    You‐Jin Choi, Kang-Yo Lee, Seung-Hwan Jung, Hyung Sik Kim, Gayong Shim, Mi-Gyeong Kim, Yu‐Kyoung Oh, Seon‐Hee Oh, Dae Won Jun, Byung‐Hoon Lee · 2016 · Toxicology and Applied Pharmacology
  49. Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice
    Hongying Li, Xin-Chen Wang, Yumin Xu, Nachuan Luo, Si Luo, Xu-Yi Hao, Shuyi Cheng, Jiansong Fang, Qi Wang, Shijie Zhang et al. · 2017 · Rejuvenation Research
  50. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression
    Chien‐shan Cheng, Hor‐Yue Tan, Ning Wang, Lianyu Chen, Zhiqiang Meng, Zhen Chen, Yibin Feng · 2021 · Clinical and Translational Medicine
  51. Lipid lowering agents of natural origin: An account of some promising chemotypes
    Suriya P. Singh, Koneni V. Sashidhara · 2017 · European Journal of Medicinal Chemistry
  52. Mitochondria and NMDA Receptor-Dependent Toxicity of Berberine Sensitizes Neurons to Glutamate and Rotenone Injury
    Kai Kysenius, Cecilia Anna Brunello, Henri J. Huttunen · 2014 · PLoS ONE
  53. Advance of studies on anti-atherosclerosis mechanism of berberine
    Min Wu, Jie Wang, Longtao Liu · 2010 · Chinese Journal of Integrative Medicine
  54. Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration
    Lidianys María Lewis Luján, Mark Frederick McCarty, James J. Di Nicolantonio, J.C. Galvez-Ruiz, Ema Carina Rosas‐Burgos, Maribel Plascencia‐Jatomea, Simon Bernard Iloki Assanga · 2022 · Nutrients
  55. Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ‐agonist activity
    Zhifen Chen, Lu Zhang, Junyang Yi, Zhuanbo Yang, Zhijie Zhang, Zhen Li · 2012 · Journal of Cellular Biochemistry
  56. Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds
    Jae Pil Lee, Myung-Gyun Kang, Joon Yeop Lee, Jong‐Min Oh, Seung Cheol Baek, Hyun Hee Leem, Daeui Park, MyoungLae Cho, Hoon Kim · 2019 · Bioorganic Chemistry
  57. AMPK activators – potential therapeutics for metabolic and other diseases
    Gaochao Zhou, Iyassu K. Sebhat, B. B. Zhang · 2009 · Acta Physiologica
  58. Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβ
    Tristan J. Iseli, Nigel A. Turner, Xiao‐Yi Zeng, Gregory James Cooney, Edward W. Kraegen, Sheng Yao, Yang Ye, David Ernest James, Ji‐Ming Ye · 2013 · PLoS ONE
  59. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview
    Carlos Villarroel-Vicente, Sergio Gutiérrez-Palomo, Jordi Ferri, Diego Cortés, Nuria Cabedo · 2021 · European Journal of Medicinal Chemistry
  60. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells
    Hsiu‐Chuan Chou, Ying-Chieh Lu, Chao‐Sheng Cheng, Yi-Wen Chen, Pingchiang C. Lyu, Cheng‐Wen Lin, John F. Timms, Hong‐Lin Chan · 2012 · Journal of Proteomics
  61. The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients.
    2012 · Europe PMC (PubMed Central)
  62. Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
    Sandeep Rana, Elizabeth C. Blowers, Amarnath Natarajan · 2014 · Journal of Medicinal Chemistry
  63. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
    Xiaopeng Zhu, Hua Bian, Xin Gao · 2016 · Molecules
  64. A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant
    Indah Purwaningsih, Iman Permana Maksum, Dadan Sumiarsa, Sriwidodo Sriwidodo · 2023 · Molecules
  65. Chromium enhances insulin responsiveness via AMPK
    Nolan J. Hoffman, Brent A. Penque, Kirk M. Habegger, Whitney Sealls, Lixuan Tackett, Jeffrey S. Elmendorf · 2014 · The Journal of Nutritional Biochemistry
  66. Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats
    Jiyin Zhou, Xiaohuang Du, Min Long, Zuo Zhang, Shiwen Zhou, Jianyun Zhou, Guisheng Qian · 2016 · European Journal of Pharmacology
  67. Repurposing Drugs to Target the Diabetes Epidemic
    Nigel A. Turner, Xiao‐Yi Zeng, Brenna Osborne, Suzanne Rogers, Ji-Ming Ye · 2016 · Trends in Pharmacological Sciences
  68. Berberine alleviates adipose tissue fibrosis by inducing AMP-Activated kinase signaling in high-fat diet-induced obese mice
    Wang, Lijun, Ye, Xiao, Hua, Yanyin, Song, Yingxiang · 2018 · Biomedicine & Pharmacotherapy
  69. Comprehensive Evaluation of SCFA Production in the Intestinal Bacteria Regulated by Berberine Using Gas-Chromatography Combined with Polymerase Chain Reaction
    Wang, Lu-Lu, Guo, Hui-Hui, Huang, Shuai, Feng, Chen-Lin, Han, Yan-Xing, Jiang, Jian-Dong · 2017 · Journal of Chromatography B
  70. Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues
    Sudip Kumar Mandal, Amal K. Maji, Siddhartha Kumar Mishra, Pir Mohammad Ishfaq, Hari Prasad Devkota, Ana T. Sanches-Silva, Niranjan Das · 2020 · Pharmacological Research
  71. Mechanisms of Berberine (Natural Yellow 18)–Induced Mitochondrial Dysfunction: Interaction with the Adenine Nucleotide Translocator
    Cláudia V. Pereira, Nuno G. Machado, Paulo Jorge Oliveira · 2008 · Toxicological Sciences
  72. Amelioration of lipid-induced insulin resistance in rat skeletal muscle by overexpression of Pgc-1β involves reductions in long-chain acyl-CoA levels and oxidative stress
    Wright, L. E., Brandon, A. E., Hoy, A. J., Forsberg, G.-B., Lelliott, C. J., Reznick, J., Löfgren, L., Oscarsson, J., Strömstedt, M., Cooney, G. J. et al. · 2011 · Diabetologia
  73. Berberine Improves Glucose and Lipid Metabolism in HepG2 Cells Through AMPKα1 Activation
    Gang Ren, Jianghong Guo, Yuzhen Qian, Weijia Kong, Jian‐Dong Jiang · 2020 · Frontiers in Pharmacology
  74. AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
    Fiona M. Russell, David Grahame Hardie · 2020 · International Journal of Molecular Sciences
  75. Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine
    Qian Zhang, Xinhua Xiao, Ming Li, Wenhui Li, Miao Yu, Huabing Zhang, Fan Ping, Zhixin Wang, Jia Zheng · 2014 · BMC Complementary and Alternative Medicine
  76. The effect of berberine supplementation on obesity indices: A dose– response meta-analysis and systematic review of randomized controlled trials
    Pan Xiong, Li Niu, Sam Talaei, Hamed Kord‐Varkaneh, Cain C. T. Clark, Mihnea‐Alexandru Găman, Jamal Rahmani, Masoumeh Dorosti, Seyed Mohammad Mousavi, Meysam Zarezadeh et al. · 2020 · Complementary Therapies in Clinical Practice
  77. Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance
    James J. DiNicolantonio, Mark Frederick McCarty, James Henry O’Keefe · 2019 · Open Heart
  78. Suppression of Lipogenesis via Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases
    Xing‐Xing Fan, Elaine Lai‐Han Leung, Ying Xie, Zhong Qiu Liu, Yan Fang Zheng, Xiao Yao, Linlin Lu, Jian‐Lin Wu, Jianxing He, Zhongwen Yuan et al. · 2017 · Antioxidants and Redox Signaling
  79. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice
    Xinzhou Yang, Jing Yang, Chan Xu, Mi Ni Huang, Qi Zhou, Jingnan Lv, Xinhua Ma, Chang‐Qiang Ke, Ye Yang, Guangwen Shu et al. · 2015 · Journal of Ethnopharmacology
  80. Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells
    Ana Burgeiro, Consuelo Gajate, El Habib Dakir, Janny A. Villa-Pulgarín, Paulo Jorge Oliveira, Faustino Mollinedo · 2011 · Anti-Cancer Drugs
  81. Berberine-induced activation of 5′-adenosine monophosphate–activated protein kinase and glucose transport in rat skeletal muscles
    Xiao Ma, Tatsuro Egawa, Hajime Kimura, Kouhei Karaike, Shinya Masuda, Nobumasa Iwanaka, Tatsuya Hayashi · 2010 · Metabolism
  82. PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain
    Thomas E. Jensen, Fiona A. Ross, Maximilian Kleinert, Lykke Sylow, Jonas R. Knudsen, Graeme J. Gowans, David Grahame Hardie, Erik Arne Richter · 2015 · Biochemical Journal
  83. Berberine Attenuates Ischemia-Reperfusion Injury Via Regulation of Adenosine-5′-monophosphate Kinase Activity in Both Non-ischemic and Ischemic Areas of the Rat Heart
    Wenguang Chang, Ming Zhang, Jing Li, Zhaojie Meng, Dong Xiao, Shengnan Wei, Li Chen, Chunyan Wang, Grant Michael Hatch · 2012 · Cardiovascular Drugs and Therapy
  84. Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria
    Sritama De Sarkar, Deblina Sarkar, Avijit Sarkar, Aishwarya Dighal, Katrin Staniek, Lars Gille, Mitali Chatterjee · 2018 · Parasitology Research
  85. AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases
    Siru Qin, Huiling Tang, Wei Li, Yinan Gong, Shanshan Li, Jin Huang, Yuxin Fang, Wenjuan Yuan, Yangyang Liu, Shenjun Wang et al. · 2020 · Current Pharmaceutical Design
  86. Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
    Jingqi Xu, Jiayan Shen, Ruolan Yuan, Bona Jia, Yiwen Zhang, Sijian Wang, Yi Zhang, Mengyang Liu, Tao Wang · 2021 · Frontiers in Pharmacology
  87. The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders
    Luca Antonioli, Rocchina Colucci, Carolina Pellegrini, Giulio Giustarini, Deborah Sacco, Erika Tirotta, Valentina Caputi, Ilaria Marsilio, Maria Cecilia Giron, Zoltán H. Németh et al. · 2015 · Expert Opinion on Therapeutic Targets
  88. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux
    Yongqiang Shan, Gang Ren, Yanxiang Wang, Jing Pang, Zhiyun Zhao, Jing Yao, Xuefu You, Shuyi Si, Danqing Song, Weijia Kong et al. · 2012 · Metabolism
  89. Oncosis-like cell death is induced by berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas
    Yuxue Sun, Jing Yu, Xinrui Liu, Chaochao Zhang, Junguo Cao, Guihong Li, Xingxing Liu, Yong Chen, Haiyan Huang · 2018 · Biomedicine & Pharmacotherapy
  90. Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
    Qian Ran, Jin Wang, Lin Wang, Hairong Zeng, Xiangbo Yang, Qinwan Huang · 2019 · Frontiers in Pharmacology
  91. Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes
    Leyuan Li, Chang Lu, Xu Zhang, Zhibin Ning, Janice Mayne, Yang Ye, Alain Stintzi, Jia Liu, Daniel Figeys · 2020 · Gut Microbes
  92. Pioglitazone Acutely Reduces Insulin Secretion and Causes Metabolic Deceleration of the Pancreatic β-Cell at Submaximal Glucose Concentrations
    Julien Lamontagne, Émilie Pépin, Marie‐Line Peyot, Erik C. Joly, Neil B. Ruderman, Vincent Poitout, S.R. Murthy Madiraju, Christopher James Nolan, Marc Prentki · 2009 · Endocrinology
  93. Tetrandrine Potentiates the Hypoglycemic Efficacy of Berberine by Inhibiting P-Glycoprotein Function
    Yongqiang Shan, Yanping Zhu, Jing Pang, Yanxiang Wang, Danqing Song, Weijia Kong, Jian‐Dong Jiang · 2013 · Biological and Pharmaceutical Bulletin
  94. Mitochondria play an important role in the cell proliferation suppressing activity of berberine
    Xiaojin Yan, Xuan Yu, Xinpei Wang, Jing-Fei Jiang, Zhiyi Yuan, Xi Lü, Lei Fan, Dongming Xing · 2017 · Scientific Reports
  95. Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
    Han, Yunfeng, Xiang, Yunan, Shi, Yi, Tang, Xi, Pan, Lin, Gao, Jie, Bi, Ruohong, Lai, Xianrong · 2021 · Evidence-Based Complementary and Alternative Medicine
  96. Berberine prevents NAFLD and HCC by modulating metabolic disorders.
    Xinyue Lin, Juan-Hong Zhang, Yajun Chu, Qiu-Ying Nie, Jun-Min Zhang · 2024 · Pharmacology and Therapeutics
  97. Targeting metabolic syndrome: Candidate natural agents
    Xuan Xia, Jianping Weng · 2010 · Journal of Diabetes
  98. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells
    Ning Wang, Xuanbin Wang, Hor‐Yue Tan, Sha Li, Chi Wai Tsang, Sai‐Wah Tsao, Yibin Feng · 2016 · International Journal of Molecular Sciences
  99. Addressing the preventive and therapeutic perspective of berberine against diabetes
    Suyesh Shrivastava, Anamika Sharma, Nishant Vibhav Saxena, Rashmi Bhamra, Sandeep Kumar · 2023 · Heliyon
  100. High-Throughput Assay for Modulators of Mitochondrial Membrane Potential Identifies a Novel Compound With Beneficial Effects on db/db Mice
    Beiying Qiu, Nigel A. Turner, Yuanyuan Li, Min Gu, Mengwei Huang, Fang Wu, Tao Pang, Fajun Nan, Ji‐Ming Ye, Jing-Ya Li et al. · 2009 · Diabetes